Healthcare - Medical - Diagnostics & Research - NASDAQ - US
$ 4.2
-3.45 %
$ 4.04 M
Market Cap
-0.23
P/E
BALANCE SHEET
15.8 M
ASSETS
6.08 M
LIABILITIES
9.74 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
iSpecimen Inc.
| Current Assets | 8.24 M |
| Cash & Short-Term Investments | 5.01 M |
| Receivables | 2.94 M |
| Other Current Assets | 292 K |
| Non-Current Assets | 7.58 M |
| Long-Term Investments | 0 |
| PP&E | 322 K |
| Other Non-Current Assets | 7.26 M |
| Current Liabilities | 6.05 M |
| Accounts Payable | 3.93 M |
| Short-Term Debt | 334 K |
| Other Current Liabilities | 1.79 M |
| Non-Current Liabilities | 29.1 K |
| Long-Term Debt | 29.1 K |
| Other Non-Current Liabilities | 0 |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 2.3 | 15.3 | 27.7 | 0.7 | 53.9 K | 1.1 |
| Short Term Investments | 2.7 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 2.9 | 3.9 | 4.9 | 2.4 | 1.4 | 1.0 |
| Inventory | 0 | 1 | (3.0) | 0 | 54.9 K | 47.3 K |
| Other Current Assets | 0.3 | 0.3 | 0.3 | 0.4 | 0.2 | 0.1 |
| Total Current Assets | 8.2 | 19.7 | 32.9 | 3.5 | 1.6 | 2.3 |
| PP&E | 0.3 | 0.4 | 32.8 K | 75.6 K | 0.1 | 0.1 |
| Intangible Assets | 7.2 | 4.5 | 2.7 | 2.6 | 2.3 | 1.4 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 0 | 0 | 0.2 | 0.1 |
| Other Long Term Assets | 27.6 K | 27.6 K | 27.6 K | 27.6 K | 0.2 | 0.2 |
| Other Assets | 1 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 15.8 | 24.6 | 35.7 | 6.2 | 4.2 | 4.0 |
| LIABILITIES | ||||||
| Accounts Payable | 3.9 | 2.5 | 0.8 | 1.8 | 0.7 | 0.7 |
| Short Term Debt | 0.3 | 0.3 | 0 | 12.6 | 10.6 | 7.0 |
| Other Current Liabilities | 1.2 | 1.4 | 1.0 | 6.9 | 4.4 | 3.6 |
| Total Current Liabilities | 6.0 | 4.3 | 2.5 | 22.1 | 15.8 | 11.3 |
| Long Term Debt | 29.1 K | 27.4 K | 3.4 | 0.2 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 | 11.2 | 0 | 0 |
| Total Liabilities | 6.1 | 4.3 | 5.9 | 33.5 | 26.9 | 22.5 |
| EQUITY | ||||||
| Common Stock | 908 | 892 | 873 | 94 | 537 | 537 |
| Retained Earnings | (59.4) | (48.3) | (38.0) | (29.1) | (24.4) | (19.7) |
| Other Accumulative Comprehensive Income/Loss | 840 | 0 | (35.7) | 0 | 0 | (0.2) |
| Total Equity | 9.7 | 20.3 | 29.8 | (27.3) | (22.7) | (18.4) |
| Total Liabilities and Equity | 15.8 | 24.6 | 35.7 | 6.2 | 4.2 | 4.0 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 9.0 | 0.4 | 0.4 | 46.8 K | 46.8 K | 46.9 K |